Altinoy Kamilova | Medicine and Dentistry | Best Review Article Award

Published on by Best Paper Awards

Best Review Article Award

Altinoy Kamilova

Republican Specialized Scientific and Practical Medical Center of Pediatrics, Uzbekistan

Altinoy Kamilova
Affiliation Republican Specialized Scientific and Practical Medical Center of Pediatrics
Country Uzbekistan
Scopus ID 6603459264
Documents 41
Citations 65
h-index 4
Subject Area Medicine and Dentistry
Event International Research Excellence and Best Paper Awards
ORCID 0000-0003-1695-0978

Altinoy Kamilova is a medical researcher affiliated with the Republican Specialized Scientific and Practical Medical Center of Pediatrics in Uzbekistan. Her research contributions are associated with medicine, dentistry, pediatric healthcare, and the investigation of gastrointestinal disorders. Her review article, Biomarkers for Intestinal Damage in Pediatric Celiac Disease, addresses emerging approaches to identifying and monitoring intestinal injury in children affected by celiac disease. [1]

 Abstract

The review article Biomarkers for Intestinal Damage in Pediatric Celiac Disease examines the potential role of biological markers in assessing intestinal injury among children diagnosed with celiac disease. Celiac disease is an immune-mediated condition associated with gluten exposure in genetically susceptible individuals and can result in inflammation and damage to the small intestinal mucosa. Conventional diagnostic approaches include serological investigations and intestinal biopsy, but these methods have limitations in evaluating ongoing intestinal injury and monitoring mucosal recovery. [1]

Keywords

Celiac disease, pediatric medicine, biomarkers, intestinal damage, intestinal fatty acid-binding protein, citrulline, gluten immunogenic peptides, zonulin, fecal calprotectin, intestinal permeability, mucosal healing, gastrointestinal health, gluten-free diet, medical research, clinical biomarkers. [1]

 Introduction

Celiac disease is a chronic immune-mediated gastrointestinal disorder triggered by gluten consumption in individuals with a genetic predisposition. It can cause inflammation and structural changes in the small intestinal mucosa, potentially affecting nutrient absorption, growth, and overall health, particularly during childhood. Accurate diagnosis and continued monitoring are important components of pediatric disease management. [1]

Research Profile

Altinoy Kamilova is affiliated with the Republican Specialized Scientific and Practical Medical Center of Pediatrics, Uzbekistan. Her scholarly profile is represented in the medical and dentistry research domain, with a publication record and citation information identified through her Scopus author profile. Her ORCID identifier provides an additional persistent academic identity for research attribution and publication discovery. [2] [3]

 Research Contributions

The review article contributes to the scientific discussion of potential biomarkers for identifying intestinal damage and evaluating disease activity in pediatric celiac disease. It brings together different categories of biomarkers and considers their possible applications in clinical assessment and follow-up. [1]

 Publications

Altinoy Kamilova’s identified scholarly contribution includes a review article addressing biomarkers for intestinal damage in pediatric celiac disease. The publication examines diagnostic and monitoring approaches relevant to pediatric gastrointestinal research and highlights opportunities for further investigation into non-invasive clinical biomarkers. [1]

 Research Impact

Research into biomarkers for pediatric celiac disease has potential relevance to clinical diagnostics, gastrointestinal medicine, and long-term patient monitoring. Identifying reliable indicators of intestinal injury could help researchers and clinicians investigate disease activity, dietary adherence, and mucosal recovery. The review contributes to this research direction by bringing together findings from different biomarker categories. [1]

 Award Suitability

The Best Review Article Award recognizes scholarly review contributions that demonstrate academic relevance, critical engagement with scientific literature, clarity of presentation, and potential value to a research discipline. Review articles can contribute to scientific progress by organizing existing evidence, identifying research gaps, and highlighting emerging directions for future investigation.

Conclusion

Altinoy Kamilova’s research contribution to the review of biomarkers for intestinal damage in pediatric celiac disease represents a relevant scholarly contribution to pediatric medicine and gastrointestinal research. [1] [2]

References

  1. Usmonova, K., Kamilova, A., Geller, S., & Umarnazarova, Z. (2026). Biomarkers for intestinal damage in pediatric celiac disease. Frontiers in Pediatrics, 14, Article 2000459. Mini Review. DOI: 10.3389/fped.2026.2000459.
    https://doi.org/10.3389/fped.2026.2000459
  2. Elsevier. (n.d.). Scopus author details: Altinoy Kamilova, Author ID 6603459264. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6603459264
  3. ORCID. (n.d.). Altinoy Kamilova – ORCID researcher identifier 0000-0003-1695-0978. ORCID.
    https://orcid.org/0000-0003-1695-0978
  4. Best Paper Awards. (n.d.). Best Paper Awards – Official Website
    .https://bestpaperawards.com/

Iraj Alipourfard | Biomedical Sciences | Best Researcher Award

Published on by Best Paper Awards

Dr. Iraj Alipourfard | Biomedical Sciences | Best Researcher Award 

Researcher, at Institute of Physical Chemistry Polish Academy of Sciences, Poland.

Summary

Dr. Iraj Alipourfard is a distinguished researcher and educator specializing in biomedical sciences, nanotechnology, and tissue engineering. Currently serving as a Postdoctoral Research Associate at the Institute of Physical Chemistry, Polish Academy of Sciences, he contributes to groundbreaking projects in organ-on-chip systems, regenerative therapy, and nanoparticle applications. With over 20 years of experience in academia and clinical practice, Dr. Alipourfard has lectured in biochemistry, molecular biology, and pharmacology across institutions in Iran, Armenia, and Poland. His multidisciplinary expertise spans cell encapsulation, microfluidics, and advanced molecular diagnostics. A prolific author and reviewer, he is also a martial arts champion with a black belt in judo.

Professional Profile

Scopus

Google Scholar

ORCID

Education

🎓 Dr. Alipourfard holds a Master of Science in Medical Analytic Laboratory Sciences from Tehran University of Medical Sciences (2005), where his thesis explored genetic disruptions in Saccharomyces cerevisiae. He completed a postdoctoral training in Clinical Biochemistry at Iran University of Medical Sciences (2022). Additionally, he earned a Postgraduate Diploma in Nutrition from the University of Vocational Education, Poland (2022). His academic foundation integrates biomedical research with applied clinical diagnostics, preparing him for interdisciplinary innovations in biomedicine.

Experience

🧪 Dr. Alipourfard is currently a Postdoctoral Research Associate at the Institute of Physical Chemistry, Polish Academy of Sciences. His work involves developing microfluidics-assisted 3D cell cultures and encapsulated pancreatic hydrogels for regenerative therapies. Previously, he was a University Research Assistant at the University of Silesia, investigating gut microbiota’s role in diabetes. He also lectured in biochemistry and genetics at Yerevan Haybusak University and managed medical laboratories at hospitals in Iran. His expertise in biomedical laboratory techniques and academic instruction has been a cornerstone of his career.

Research Interests

🔬 Dr. Alipourfard’s research interests center on regenerative medicine, nanobiotechnology, and tissue engineering. He focuses on microfluidic systems for T-regulatory lymphocyte encapsulation, anti-bacteriophage nanoparticle synthesis, and organoid modeling for drug sensitivity assays. His work also explores the interplay of gut microbiota in diabetes and obesity. Passionate about translational science, Dr. Alipourfard aims to bridge the gap between bench research and clinical applications, especially in autoimmune therapy and cancer diagnostics.

Awards

🏆 Dr. Alipourfard’s accolades include the LazioDisco Italian Governmental Scholarship (2016–2018), the Erasmus Internship Award (2018–2019), and the Best Presentation Award at a Clinical Microbiology Conference in Shiraz, Iran. He also secured the First Ranking Position in the admission test for the Master of Pharmacy program at the University of Rome Tor Vergata. His diverse honors reflect his academic excellence, international collaborations, and impactful contributions to biomedical sciences.

Top Noted Publications

📚 Dr. Alipourfard has authored 65 scientific articles, two book chapters on cancer and nanotechnology, and numerous conference papers. Below are selected publications with hyperlinks:

  • “The Role of Akt Protein Kinase in Metabolic-Inflammatory Pathways Cross-Talk”
    Published in: Journal of Biochemistry, 2019

    • Cited by: 150 articles
    • This study investigates the interaction between Akt protein kinase and metabolic-inflammatory pathways, with an emphasis on how TNF-α regulation can improve insulin resistance in HepG2 cells. The research contributes to understanding the role of Akt in managing metabolic disorders.
  • “Molecular Evaluation of Methicillin-Resistant Staphylococcus aureus”
    Published in: Clinical Microbiology & Infection, 2010

    • Cited by: 300 articles
    • This article presents an in-depth molecular analysis of methicillin-resistant Staphylococcus aureus (MRSA), focusing on its genetic and antimicrobial resistance profiles. The findings provide significant insights into the epidemiology and molecular mechanisms of MRSA in healthcare settings.
  • “Nanomedicine: A New Frontier of Nanotechnology in Clinical Practice”
    Published in: Advanced Research in Physics Conference Proceedings, 2009

    • This paper explores the potential applications of nanomedicine, highlighting the transformative role of nanotechnology in diagnosing and treating diseases. The work sheds light on how nanomedicine could revolutionize clinical practices, enhancing therapeutic delivery and diagnostic capabilities.

Conclusion

Iraj Alipourfard is a highly qualified researcher with a robust portfolio of innovative research, practical applications, and academic teaching. His impressive list of awards, publications, and ongoing research projects positions him as an ideal candidate for the Best Researcher Award. With continued interdisciplinary collaboration and expansion of his research influence, he is poised to make even greater contributions to the scientific community.